Mohamed S. Elafify, Nermeen A. Elkasabgy, Sinar Sayed, Yoshihiro Ito, Motoki Ueda
{"title":"Shear Stress-Responsive Peptide Cubic Vesicles Assembled from Membranes with Different Curvatures","authors":"Mohamed S. Elafify, Nermeen A. Elkasabgy, Sinar Sayed, Yoshihiro Ito, Motoki Ueda","doi":"10.1002/smll.202409582","DOIUrl":null,"url":null,"abstract":"Stenotic blood vessels differ from normal blood vessels in that the blood flow shear stress is increased to a higher order of magnitude. Therefore, drug delivery systems (DDSs) capable of responding to changes in the shear stress are highly desirable. To prepare sheer stress-responsive carriers, a peptide cubic vesicle (PCV) is prepared by combining two types of sheet-forming amphiphilic polypeptides: planar sheet-forming GA-(PSar)<sub>10</sub>-<i>b</i>-(<span>l</span>-Leu-Aib)<sub>6</sub>-<i>b</i>-(PSar)<sub>10</sub>-GA (S<sub>10</sub>L<sub>12</sub>S<sub>10</sub>) and curved sheet-forming GA-(PSar)<sub>24</sub>-<i>b</i>-(<span>l</span>-Leu-Aib)<sub>7</sub> (S<sub>26</sub>L<sub>14</sub>), which GA, PSar, Leu and Aib mean glycolic acid, polysarcosine, leucine and α-aminoisobutyric acid. The PCV is successfully constructed from a mixture of S<sub>10</sub>L<sub>12</sub>S<sub>10</sub> and S<sub>26</sub>L<sub>14</sub> in molar ratios of 2:1 and 1:1. In addition, curved S<sub>26</sub>L<sub>14</sub> membrane forms edges and corners, while planar S<sub>10</sub>L<sub>12</sub>S<sub>10</sub> membrane forms the faces of the PCV. Notably, the PCV deforms under pathological shear stress conditions (10 Pa) but retains its original structure under the normal physiological shearing force of 1 Pa. Moreover, the PCV releases 84% of its encapsulated cargo in response to simulated pathological flow. Targeting the changing biophysical environment for drug development has the potential to shift the paradigm for treating vascular occlusion-inducing diseases from biochemical to mechanical stimulation, thereby lowering the required dose and side effects of drugs while maximizing their therapeutic efficacy.","PeriodicalId":228,"journal":{"name":"Small","volume":"67 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Small","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1002/smll.202409582","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Stenotic blood vessels differ from normal blood vessels in that the blood flow shear stress is increased to a higher order of magnitude. Therefore, drug delivery systems (DDSs) capable of responding to changes in the shear stress are highly desirable. To prepare sheer stress-responsive carriers, a peptide cubic vesicle (PCV) is prepared by combining two types of sheet-forming amphiphilic polypeptides: planar sheet-forming GA-(PSar)10-b-(l-Leu-Aib)6-b-(PSar)10-GA (S10L12S10) and curved sheet-forming GA-(PSar)24-b-(l-Leu-Aib)7 (S26L14), which GA, PSar, Leu and Aib mean glycolic acid, polysarcosine, leucine and α-aminoisobutyric acid. The PCV is successfully constructed from a mixture of S10L12S10 and S26L14 in molar ratios of 2:1 and 1:1. In addition, curved S26L14 membrane forms edges and corners, while planar S10L12S10 membrane forms the faces of the PCV. Notably, the PCV deforms under pathological shear stress conditions (10 Pa) but retains its original structure under the normal physiological shearing force of 1 Pa. Moreover, the PCV releases 84% of its encapsulated cargo in response to simulated pathological flow. Targeting the changing biophysical environment for drug development has the potential to shift the paradigm for treating vascular occlusion-inducing diseases from biochemical to mechanical stimulation, thereby lowering the required dose and side effects of drugs while maximizing their therapeutic efficacy.
期刊介绍:
Small serves as an exceptional platform for both experimental and theoretical studies in fundamental and applied interdisciplinary research at the nano- and microscale. The journal offers a compelling mix of peer-reviewed Research Articles, Reviews, Perspectives, and Comments.
With a remarkable 2022 Journal Impact Factor of 13.3 (Journal Citation Reports from Clarivate Analytics, 2023), Small remains among the top multidisciplinary journals, covering a wide range of topics at the interface of materials science, chemistry, physics, engineering, medicine, and biology.
Small's readership includes biochemists, biologists, biomedical scientists, chemists, engineers, information technologists, materials scientists, physicists, and theoreticians alike.